AI and biotech drug development
|
4
|
Zenith Epigenetics
|
Sep 03, 2023 11:18AM
|
Re: Review of ZCC history
|
1
|
Zenith Epigenetics
|
Aug 29, 2023 03:07PM
|
Re: Review of ZCC history
|
4
|
Zenith Epigenetics
|
Aug 29, 2023 11:40AM
|
Re: Review of ZCC history
|
4
|
Zenith Epigenetics
|
Aug 29, 2023 09:50AM
|
Re: Financial Statement Q2, 2023 /MD&A
|
4
|
Resverlogix Corp.
|
Aug 13, 2023 04:18PM
|
Re: AGM Oct 26, 2023
|
8
|
Zenith Epigenetics
|
Aug 13, 2023 10:14AM
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 25, 2023 07:00AM
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 22, 2023 07:54AM
|
Re: What's the deal with Zenith?
|
6
|
Zenith Epigenetics
|
Jun 24, 2023 02:29PM
|
Re: Link to 2023 AGM presentation is up
|
1
|
Resverlogix Corp.
|
Jun 22, 2023 02:01PM
|
Re: AGM
|
2
|
Resverlogix Corp.
|
Jun 20, 2023 11:45AM
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
2
|
Resverlogix Corp.
|
Jun 12, 2023 06:15PM
|
Re: Down 53% today
|
1
|
Zenith Epigenetics
|
Jun 08, 2023 12:07PM
|
Re: New Phase 1 NCI trial
|
6
|
Zenith Epigenetics
|
May 24, 2023 07:09PM
|
Re: VP of clinical operations
|
2
|
Zenith Epigenetics
|
May 21, 2023 06:26PM
|
Re: IR - "but all I can tell you at the moment is that we believe we are making real progress towards achieving our goals."
|
5
|
Resverlogix Corp.
|
May 17, 2023 02:42PM
|
Re: IR - "but all I can tell you at the moment is that we believe we are making real progress towards achieving our goals."
|
6
|
Resverlogix Corp.
|
May 11, 2023 02:18PM
|
Re: So what's our ceo's next move/plan? one thought ...
|
3
|
Resverlogix Corp.
|
Apr 26, 2023 12:16PM
|
Re: Sales could take a hit
|
5
|
Resverlogix Corp.
|
Apr 18, 2023 11:30AM
|
Re: Sales could take a hit
|
3
|
Resverlogix Corp.
|
Apr 17, 2023 06:41PM
|